Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: CRC Detection Reliable Assessment With Blood

View source ↗

Summary

A New Day Diagnostics trial is evaluating a blood-based method for detecting colorectal cancer and colorectal adenomas; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: New Day Diagnostics | Conditions: Colorectal Cancer, Adenomas Colon | Status: ACTIVE_NOT_RECRUITING